Fully bioresorbable vascular scaffold technology may offer good alternative to coronary stenting

There have been studies showing that Abbott's bioresorbable vascular scaffold (BVS) may be able to resolve coronary artery disease. There was no sign of adverse effects such as thrombosis. The BVS is made of a polylactide material. It is a biocompatible material that is able to heal clogged arteries. This material provides support for the artery until the artery can support itself on its own and blood can flow freely through the vessel. After the polylactide has done it's job, it is able to metabolize and be reabsorbed into the body.

The major advantage of the BVS is that there is no implant into the arteries. Eventually, the artery may be able to function like a normal artery and be able to move, flex, and pulsate. Of the patients that were involved in this study, there were none that reported to have blood clots after 6 months into the study.

I found this article interesting because in class, our design projects are dealing with the treatment of coronary artery disease (CAD). It is very interesting to read about a possible cure for CAD after researching so much about it. Since the study shows that there is no occurrence of restenosis or thrombosis so far in the study, it seems like there could be few, if any side effects. Also, if the polylactide material is a successful resolution, this could lead to a huge leap forward in the treatment of CAD in the future.

Article: http://findarticles.com/p/articles/mi_hb5970/is_2010_Nov/ai_n56259675/?tag=content;col1